A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma: A prospective study

scientific article published on 29 June 2011

A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma: A prospective study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CNCY.20168
P698PubMed publication ID21717592

P2093author name stringJosep Lloreta
Francesc Solé
Marta Salido
Blanca Espinet
Antoni Gelabert-Mas
José Placer
Lara Pijuan
Ana B Galván
Núria Juanpere
P2860cites workFluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic studyQ34361348
The role of hexaminolevulinate fluorescence cystoscopy in bladder cancerQ36964427
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladderQ37158767
Bladder cancer biomarkers and their role in surveillance and screeningQ37361497
Flourescence cystoscopy--how to do it.Q37438866
A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosisQ37781786
The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urineQ42721217
Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapyQ44505075
Bladder cancer: epidemiology, staging and grading, and diagnosis.Q45247416
UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testingQ45374139
A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapyQ46648283
Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization.Q53628297
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinomaQ73062815
The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancerQ76352148
Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytologyQ78644394
Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findingsQ79517685
The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancerQ80206379
The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancerQ81204170
Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practiceQ81479508
Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytologyQ81505387
Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samplesQ81637608
Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancerQ83216597
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapyQ83381017
Reflex UroVysion testing in suspicious urine cytology casesQ83612735
P433issue6
P304page(s)395-403
P577publication date2011-06-29
P1433published inCancer CytopathologyQ13452937
P1476titleA multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma: A prospective study
P478volume119

Reverse relations

cites work (P2860)
Q36340124A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection
Q37435097Diagnosis of bladder cancer from the voided urine specimens using multi-target fluorescence in situ hybridization
Q60302268Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma
Q37238810Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation
Q37705271Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy
Q92487538Significant lack of urine-based biomarkers to replace cystoscopy for the surveillance of non-muscle invasive bladder cancer
Q35147519Size-based enrichment of exfoliated tumor cells in urine increases the sensitivity for DNA-based detection of bladder cancer
Q45139625Urine cytology - update 2013. A systematic review of recent literature
Q91756608Urovysion FISH Could Be Effective and Useful Method to Confirm the Identity of Cultured Circulating Tumor Cells from Bladder Cancer Patients
Q53572489[Non-muscle-invasive high-grade bladder cancer].

Search more.